Medtronic Inc. (MDT): Today's Featured Health Services Winner

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Medtronic ( MDT) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 2.2%. By the end of trading, Medtronic rose 71 cents (1.7%) to $41.81 on average volume. Throughout the day, 5.1 million shares of Medtronic exchanged hands as compared to its average daily volume of 4.5 million shares. The stock ranged in a price between $41.31-$41.81 after having opened the day at $41.36 as compared to the previous trading day's close of $41.10. Other companies within the Health Services industry that increased today were: BioMimetic Therapeutics ( BMTI), up 74.2%, CombiMatrix Corporation ( CBMX), up 41.7%, Span-America Medical ( SPAN), up 22.5%, and Rockwell Medical ( RMTI), up 10.5%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. Medtronic has a market cap of $41.69 billion and is part of the health care sector. The company has a P/E ratio of 12.5, below the S&P 500 P/E ratio of 17.7. Shares are up 7.5% year to date as of the close of trading on Friday. Currently there are 11 analysts that rate Medtronic a buy, no analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, notable return on equity and attractive valuation levels. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

FREE for a limited time only: Get TheStreet Ratings #1 Stock Report NOW!.
null

If you liked this article you might like

Medtronic Looks Vulnerable to a Bigger Decline

FDA Approves Abbott Heart Device, Stock Rises

Measure the Meaning of This Rally: Cramer's 'Mad Money' Recap (Tues 8/22/17)

The 10 Stocks America's Biggest Hedge Funds Are Dumping Like Crazy

Cramer: This Rally Isn't Without Meaning